Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at HUF 9.12T, ahead of Eli Lilly (HUF 7.03T) and Merck & Co (HUF 6.21T). Figures as of 20 Nov 2026, 19:36 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonHUF 9.12T
- Median
- -HUF 16.3B
- Combined market value
- HUF 1277.59T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | HUF 9.12T | HUF 222.57T | HUF 92,457.02 | 1.68% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | HUF 7.03T | HUF 409.63T | HUF 459,875.31 | 0.00% | 28% up | ||
| 3 | Merck & CoMRK · Health Care | HUF 6.21T | HUF 112.83T | HUF 45,769.02 | 1.25% up | 36% up | ||
| 4 | PfizerPFE · Health Care | HUF 2.64T | HUF 53.42T | HUF 9,371.98 | 0.02% down | 10% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | HUF 2.4T | HUF 41.1T | HUF 20,108.82 | 1.27% up | 26% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | HUF 2.22T | HUF 61.12T | HUF 35,289.15 | 0.18% down | 19% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | HUF 1.53T | HUF 32.43T | HUF 313,536.75 | 0.13% down | 22% up | ||
| 8 | AbbVieABBV · Health Care | HUF 1.44T | HUF 173.48T | HUF 98,142.83 | 1.69% up | 20% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | HUF 1.35T | HUF 44.79T | HUF 176,677.18 | 0.30% down | 22% up | ||
| 10 | ZoetisZTS · Health Care | HUF 909.8B | HUF 11.03T | HUF 27,140.78 | 1.30% down | 34% down | ||
| 11 | United TherapeuticsUTHR · Health Care | HUF 454.3B | HUF 8.04T | HUF 188,879.30 | 0.75% down | 18% up | ||
| 12 | Royalty PharmaRPRX · Health Care | HUF 262.4B | HUF 13.35T | HUF 23,223.17 | 0.75% up | 74% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | HUF 232.3B | HUF 1.63T | HUF 19,455.35 | 2.00% down | 26% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | HUF 152.2B | HUF 3.31T | HUF 21,882.13 | 0.91% down | 103% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | HUF 118.8B | HUF 3.98T | HUF 20,546.19 | 1.72% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | HUF 106.8B | HUF 6.69T | HUF 49,972.54 | 0.68% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | HUF 42.4B | HUF 1.95T | HUF 97,594.85 | 0.07% down | 44% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | HUF 33.9B | HUF 2.36T | HUF 21,586.01 | 2.40% down | 16% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | HUF 24.5B | HUF 2.52T | HUF 7,225.97 | 0.75% down | 79% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -HUF 555.1M | HUF 2.02T | HUF 14,298.78 | 3.76% down | 8% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -HUF 8B | HUF 2.16T | HUF 33,141.44 | 1.95% up | 35% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -HUF 8.7B | HUF 1.56T | HUF 16,286.51 | 0.93% down | 39% up | ||
| 23 | VeradermicsMANE · Health Care | -HUF 23.8B | HUF 1.72T | HUF 40,775.85 | 3.69% down | 230% up | ||
| 24 | Belite BioBLTE · Health Care | -HUF 26.4B | HUF 1.84T | HUF 45,302.71 | 11.87% down | 25% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -HUF 35.9B | HUF 2.17T | HUF 32,004.61 | 3.63% down | 233% up | ||
| 26 | ErascaERAS · Health Care | -HUF 42.4B | HUF 1.65T | HUF 4,691.95 | 3.06% down | 387% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -HUF 44.3B | HUF 2.72T | HUF 41,636.97 | 1.36% down | 45% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -HUF 52.8B | HUF 3.05T | HUF 32,145.87 | 3.26% down | 302% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -HUF 55.3B | HUF 1.6T | HUF 28,488.63 | 1.33% down | 105% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -HUF 57.1B | HUF 1.5T | HUF 13,696.33 | 2.26% down | 82% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -HUF 62.3B | HUF 2.32T | HUF 44,138.66 | 4.42% down | 9% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -HUF 62.6B | HUF 1.34T | HUF 9,812.75 | 2.20% down | 176% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -HUF 66.9B | HUF 2.73T | HUF 39,387.15 | 0.92% down | 15% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -HUF 79B | HUF 4.36T | HUF 8,723.58 | 2.51% down | 18% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -HUF 98.1B | HUF 3.06T | HUF 131,609.32 | 2.54% down | 28% down | ||
| 36 | Legend BiotechLEGN · Health Care | -HUF 101B | HUF 1T | HUF 5,180.37 | 5.47% down | 43% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -HUF 103.2B | HUF 2.89T | HUF 103,447.44 | 2.24% down | 83% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -HUF 112B | HUF 1.59T | HUF 9,149.04 | 3.10% down | 25% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -HUF 129.8B | HUF 1.54T | HUF 9,220.51 | 0.48% down | 64% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -HUF 249.5B | HUF 5.07T | HUF 26,020.98 | 2.21% down | 15% up | ||
| 41 | CytokineticsCYTK · Health Care | -HUF 267.2B | HUF 2.43T | HUF 17,428.44 | 0.50% down | 21% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -HUF 367.5B | HUF 2.74T | HUF 3,420.68 | 4.92% down | 35% down | ||
| 43 | InsmedINSM · Health Care | -HUF 434.6B | HUF 10.64T | HUF 48,488.54 | 1.38% down | 27% down | ||
| 44 | ViatrisVTRS · Health Care | -HUF 1.2T | HUF 7.64T | HUF 6,661.00 | 1.56% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 340.4 HUF).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (HUF 9.12T), Eli Lilly (HUF 7.03T) and Merck & Co (HUF 6.21T) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 19:36 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of HUF 1277.59T as of 20 Nov 2026, 19:36 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.